Giuseppe Curigliano to Pneumonia, Viral
This is a "connection" page, showing publications Giuseppe Curigliano has written about Pneumonia, Viral.
Connection Strength
0.281
-
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus. Ann Oncol. 2020 10; 31(10):1320-1335.
Score: 0.028
-
Cancer Patients and Risk of Mortality for COVID-19. Cancer Cell. 2020 08 10; 38(2):161-163.
Score: 0.028
-
ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer. ESMO Open. 2020 05; 5(Suppl 3).
Score: 0.028
-
The experience on coronavirus disease 2019 and cancer from an oncology hub institution in Milan, Lombardy Region. Eur J Cancer. 2020 06; 132:199-206.
Score: 0.028
-
How to Guarantee the Best of Care to Patients with Cancer During the COVID-19 Epidemic: The Italian Experience. Oncologist. 2020 06; 25(6):463-467.
Score: 0.028
-
Effect of the COVID-19 pandemic on cancer treatment and research. Lancet Haematol. 2020 06; 7(6):e432-e435.
Score: 0.028
-
Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020 Aug; 52:8-16.
Score: 0.028
-
Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease pandemic. Eur J Cancer. 2020 06; 132:8-10.
Score: 0.028
-
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies. Eur J Cancer. 2020 11; 139:43-50.
Score: 0.007
-
Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study. JCO Glob Oncol. 2020 09; 6:1428-1438.
Score: 0.007
-
Delivering Cancer Care During the COVID-19 Pandemic: Recommendations and Lessons Learned From ASCO Global Webinars. JCO Glob Oncol. 2020 Sep; 6:1461-1471.
Score: 0.007
-
Repurposing anticancer drugs for COVID-19-induced inflammation, immune dysfunction, and coagulopathy. Br J Cancer. 2020 09; 123(5):694-697.
Score: 0.007
-
Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019. Eur J Cancer. 2020 08; 135:62-65.
Score: 0.007
-
In Reply. Oncologist. 2020 08; 25(8):e1252-e1253.
Score: 0.007
-
Risk of coronavirus disease 2019 in patients treated for cancer: An immune response-based hypothesis. Eur J Cancer. 2020 07; 134:6-8.
Score: 0.007
-
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020 06; 25(6):e936-e945.
Score: 0.007